A new development that will temporarily suspend Tetra Bio-Pharma's (Tetra Bio-Pharma Stock Quote, Chart TSXV:TBP) Phase 3 clinical program has … [Read more...] about Tetra Bio-Pharma is a buy despite toxin scare, Paradigm Capital says
Cannabis
Your company can reach thousands of cannabis sector investors by becoming the exclusive annual sponsor of this section. Contact us for details.
Cronos Group downgraded to “Hold” at GMP
As Cronos Group (Cronos Group Stock Quote, Chart TSX:CRON) hits all time highs, GMP Securities analyst Martin Landry says he is heading for the … [Read more...] about Cronos Group downgraded to “Hold” at GMP
Village Farms is the best risk-return stock in the cannabis sector: Beacon
Beacon Securities analyst Doug Cooper says "significant" supply issues facing the Canadian market underscore the value in Village Farms International … [Read more...] about Village Farms is the best risk-return stock in the cannabis sector: Beacon
Trulieve Cannabis has a 71 per cent upside, Beacon Securities says
Florida-based cannabis company Trulieve Cannabis (Trulieve Cannabis Stock Quote, Chart CSE:TRUL) is getting more room to run, says analyst Russell … [Read more...] about Trulieve Cannabis has a 71 per cent upside, Beacon Securities says
Canopy Growth Corp needs five or six good years to justify current valuation, this investor says
All eyes will be on Canopy Growth Corp (Canopy Growth Corp Stock Quote, Chart TSX:WEED) next week as the cannabis kingpin releases its quarterly … [Read more...] about Canopy Growth Corp needs five or six good years to justify current valuation, this investor says
Canopy Growth could become bigger than Constellation Brands, Bruce Linton says
At this year’s Cantech Investment Conference, Canopy Growth CEO and co-founder Bruce Linton sat down with Globe and Mail reporter Jameson Berkow and … [Read more...] about Canopy Growth could become bigger than Constellation Brands, Bruce Linton says
Biosynthesis is the future of cannabis, not plant cultivation, Paradigm Capital says
Cannabis companies are just getting off the ground when it comes to meeting the needs of both medical and adult-use markets in Canada and abroad, but … [Read more...] about Biosynthesis is the future of cannabis, not plant cultivation, Paradigm Capital says
Canopy Growth Corp is worth (US) $60.00 a share, Piper Jaffray says
For the second time in less than a month, shares of Canopy Growth Corp (Canopy Growth Stock Quote, Chart NYSE:CGC) are getting a lift from Wall Street … [Read more...] about Canopy Growth Corp is worth (US) $60.00 a share, Piper Jaffray says
Valens GrowWorks has a 76 per cent upside, says Mackie Research
Analyst Greg McLeish of Mackie Research Capital Corporation says that recent deals snagged by Valens GrowWorks (Valens GrowWorks Stock Quote, Chart … [Read more...] about Valens GrowWorks has a 76 per cent upside, says Mackie Research
No hard feelings over rejected Super Bowl ad, Acreage Holdings CEO says
Canada may be in the lead when it comes to cannabis but 2019 should finally be the year when the United States legalizes medical marijuana, says Kevin … [Read more...] about No hard feelings over rejected Super Bowl ad, Acreage Holdings CEO says